BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bor J, Chiu C, Ahmed S, Katz I, Fox MP, Rosen S, Yapa M, Tanser F, Pillay D, Bärnighausen T. Failure to initiate HIV treatment in patients with high CD4 counts: evidence from demographic surveillance in rural South Africa. Trop Med Int Health 2018;23:206-20. [PMID: 29160949 DOI: 10.1111/tmi.13013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Katz IT, Musinguzi N, Bell K, Cross A, Bwana MB, Amanyire G, Asiimwe S, Orrell C, Bangsberg DR, Haberer JE; META (Measuring Early Treatment Adherence) Team Investigators. Brief Report: The Impact of Disease Stage on Early Gaps in ART in the "Treatment for All" Era-A Multisite Cohort Study. J Acquir Immune Defic Syndr 2021;86:562-7. [PMID: 33351529 DOI: 10.1097/QAI.0000000000002605] [Reference Citation Analysis]
2 Nardell MF, Hedt-Gauthier B, Earnshaw VA, Bogart LM, Dietrich JJ, Courtney I, Tshabalala G, Bor J, Orrell C, Gray G, Bangsberg DR, Katz IT. Understanding Repeat Positive HIV Testing in South Africa Under Changing Treatment Guidelines. AIDS Behav 2021. [PMID: 34705150 DOI: 10.1007/s10461-021-03493-5] [Reference Citation Analysis]
3 Lilian RR, Rees K, McIntyre JA, Struthers HE, Peters RPH. Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data. PLoS One 2020;15:e0227572. [PMID: 31935240 DOI: 10.1371/journal.pone.0227572] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
4 Katz IT, Bogart LM, Fitzmaurice GM, Staggs VS, Gwadz MV, Bassett IV, Cross A, Courtney I, Tsolekile L, Panda R, Steck S, Bangsberg DR, Orrell C, Goggin K. The Treatment Ambassador Program: A Highly Acceptable and Feasible Community-Based Peer Intervention for South Africans Living with HIV Who Delay or Discontinue Antiretroviral Therapy. AIDS Behav 2021;25:1129-43. [PMID: 33125587 DOI: 10.1007/s10461-020-03063-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Ahmed S, Autrey J, Katz IT, Fox MP, Rosen S, Onoya D, Bärnighausen T, Mayer KH, Bor J. Why do people living with HIV not initiate treatment? A systematic review of qualitative evidence from low- and middle-income countries. Soc Sci Med 2018;213:72-84. [PMID: 30059900 DOI: 10.1016/j.socscimed.2018.05.048] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
6 Sturt AS, Webb EL, Francis SC, Hayes RJ, Bustinduy AL. Beyond the barrier: Female Genital Schistosomiasis as a potential risk factor for HIV-1 acquisition. Acta Trop 2020;209:105524. [PMID: 32416076 DOI: 10.1016/j.actatropica.2020.105524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bayisa L, Tadesse A, Reta MM, Gebeye E. Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia. HIV AIDS (Auckl) 2020;12:457-65. [PMID: 33061657 DOI: 10.2147/HIV.S267408] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mokhele I, Sineke T, Langa J, Onoya D. Self-reported motivators for HIV testing in the treat-all era among HIV positive patients in Johannesburg, South Africa. Medicine (Baltimore) 2021;100:e25286. [PMID: 33847626 DOI: 10.1097/MD.0000000000025286] [Reference Citation Analysis]
9 Chang AY, Haber N, Bärnighausen T, Herbst K, Gareta D, Pillay D, Salomon JA. Improving the Validity of Mathematical Models for HIV Elimination by Incorporating Empirical Estimates of Progression Through the HIV Treatment Cascade. J Acquir Immune Defic Syndr 2018;79:596-604. [PMID: 30272631 DOI: 10.1097/QAI.0000000000001852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Lebelonyane R, Bachanas P, Block L, Ussery F, Abrams W, Roland M, Theu J, Kapanda M, Matambo S, Lockman S, Gaolathe T, Makhema J, Moore J, Jarvis JN. Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after study. Lancet HIV 2020;7:e545-53. [PMID: 32763218 DOI: 10.1016/S2352-3018(20)30187-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mwamba C, Beres LK, Topp SM, Mukamba N, Simbeza S, Sikombe K, Mody A, Geng E, Holmes CB, Kennedy CE, Sikazwe I, Denison JA, Bolton Moore C. 'I need time to start antiretroviral therapy': understanding reasons for delayed ART initiation among people diagnosed with HIV in Lusaka, Zambia'. Ann Med 2022;54:830-6. [PMID: 35311423 DOI: 10.1080/07853890.2022.2051069] [Reference Citation Analysis]
12 Sy KTL, Tariq S, Ramjee G, Blanchard K, Leu CS, Kelvin EA, Exner TM, Gandhi AD, Lince-Deroche N, Mantell JE, O'Sullivan LF, Hoffman S. Predictors of antiretroviral therapy initiation in eThekwini (Durban), South Africa: Findings from a prospective cohort study. PLoS One 2021;16:e0246744. [PMID: 33606712 DOI: 10.1371/journal.pone.0246744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lopez-Varela E, Augusto O, Fuente-Soro L, Sacoor C, Nhacolo A, Casavant I, Karajeanes E, Vaz P, Naniche D. Quantifying the gender gap in the HIV care cascade in southern Mozambique: We are missing the men. PLoS One 2021;16:e0245461. [PMID: 33577559 DOI: 10.1371/journal.pone.0245461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]